In the latest trading session, Alkermes (ALKS) closed at $27.74, marking a -1% move from the previous day. This move lagged the S&P 500's daily loss of 0.07%. On the other hand, the Dow registered a gain of 0.16%, and the technology-centric Nasdaq decreased by 0.36%.Coming into today, shares of the drugmaker had gained 0.5% in the past month. In that same time, the Medical sector gained 1.45%, while the S&P 500 gained 3.05%.Market participants will be closely following the financial results of Alkermes in i ...

Companies within the biotechnology industry are very interesting to investors because they see wild swings in share price following positive or negative news, particularly in the case of small biotech companies. Investing in biotech and other pharmaceutical stocks can be risky because their price action can be so swift and unpredictable.Investors looking for some riskier options for their portfolio biotech companies may be a good choice due to the possibility of significant upside. But, it is best to have l ...

Alkermes plc (NASDAQ:ALKS) Q3 2023 Results Earnings Conference Call October 25, 2023 8:00 AM ET Company Participants Sandra Coombs - Senior Vice President, Corporate Affairs and Investor Relations Iain Brown - Senior Vice President and Chief Financial Officer Todd Nichols - Senior Vice President and Chief Commercial Officer Craig Hopkinson - Executive Vice President, Research & Development and Chief Medical Officer Richard Pops - Chairman and Chief Executive Officer Conference Call Participants Amy Li - Jef ...

Third Quarter 2023 Financial Results & Business Update October 25, 2023 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-35299 https://reportify- 1252068037.cos.ap- beijing.myqcloud.com/media/produ ALKERMES PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its cha ...

Second Quarter 2023 Financial Results & Business Update July 26, 2023 ...

Alkermes plc (NASDAQ:ALKS) Q2 2023 Earnings Conference Call July 26, 2023 8:00 AM ET Company Participants Sandra Coombs – Senior Vice President-Corporate Affairs and Investor Relations Iain Brown – Chief Financial Officer Todd Nichols – Chief Commercial Officer Richard Pops – Chief Executive Officer Conference Call Participants Chris Shibutani – Goldman Sachs David Amsellem – Piper Sandler Paul Matteis – Stifel Umer Raffat – Evercore ISI Uy Ear – Mizuho Securities Marc Goodman – Leerink Partners Jason Gerbe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-35299 https://reportify- 1252068037.cos.ap- beijing.myqcloud.com/media/produ ALKERMES PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) ...

Call Start: 08:00 January 1, 0000 9:01 AM ET Alkermes plc (NASDAQ:ALKS) Q1 2023 Earnings Conference Call April 26, 2023 08:00 ET Company Participants Sandra Coombs - Senior Vice President of Investor Relations & Corporate Affairs Richard Pops - Chief Executive Officer Iain Brown - Chief Financial Officer Todd Nichols - Chief Commercial Officer Conference Call Participants Akash Tiwari - Jeffries Brandon Folkes - Cantor Fitzgerald Umer Raffat - Evercore ISI Chris Shibutani - Goldman Sachs David Amsellem - Pi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-35299 ALKERMES PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 98-1007018 (State or other jurisdiction of incorporation or o ...